Sex Steroids – Improving Treatment after Doping and in Transgender Persons

Sex Steroids – Improving Treatment after Doping and in Transgender Persons

Sex steroids have received increased attention in various settings. In transgender persons, sex steroids are used clinically as a gender affirming treatment. Among recreational athletes, steroids are used illicitly to gain increased muscle strength and performance. 

With the rapid expansion of the use of sex steroids, there is an increasing need to understand the consequences of sex steroids use in transgender persons. Further, in doping, there is a need to increase the knowledge on how to handle the consequences of long-term illicit steroid use. 

Over two days, this DDEA meeting brings together clinicians and researchers of all career levels engaged or interested in the health and treatment of doping patients and transgender persons. The primary aims of the event are to provide a forum for raising awareness, widening and deepening the knowledge base about how to best manage and care for these groups of people, and connecting people with similar research and clinical interests across Denmark and beyond Danish borders. 

At the meeting, you will delve into cutting-edge findings – beginning with a review of these rapidly growing fields, then moving into a focus on mental health aspects, best clinical practices related to treatment, and much more.

This meeting will deepen and widen your knowledge about the clinical treatment after doping and in transgender persons. 

During the meeting, you will explore:

  • Physiological effects of sex hormones on health 
  • Transgender treatment and research on use of gender affirming hormone treatment
  • The development within the illicit use of androgenic steroids 
  • The mental health aspects 
  • How to improve clinical treatment 
  • Cardiovascular impacts after sex steroids use
  • The side effects of steroid use – metabolic, cardiovascular, pituitary, etc.

 

After participating in this two-day meeting you will have a better understanding of what gender-affirming hormone treatment is. You will be able to navigate the sensitive and political nature of the topic. In addition you will be better able to understand the symptoms and complaints of persons of long-term use of androgenic steroids. 

A debate session at the end of day one will further provide the opportunity for sharing knowledge across research fields, areas of expertise and borders. We aim to support a safe and comfortable environment for all participants to gain new insights into these fields.

Speakers and experts:

  • Ask Vest Christiansen, Ask Vest Christiansen, Aarhus University (DK)
  • Astrid Højgaard, Associate Professor, Aalborg University Hospital (DK)
  • Caroline Kistorp, Professor, Rigshospitalet (DK)
  • Chantal Wiepjes, Assistant Professor, Amsterdam UMC (NL) 
  • Elisabet Stener-Victorin, Professor, Karolinska Institutet (SE)
  • John Gleaves, Professor, California State University Fullerton (US)
  • Jon Bjarke Jarløv Rasmussen, Postdoc, Rigshospitalet (DK)
  • Justine Defreyne, Researcher, Ghent University Hospital (BE)
  • Margot Morssinkhof, Researcher, Amsterdam UMC (NL) 
  • Morten Hostrup, Associate Professor, University of Copenhagen (DK)
  • Nikos Ntoumanis, Professor, University of Southern Denmark (DK)
  • Vibe Frøkjær, Professor, Copenhagen University Hospital, Rigshospitalet (DK)
  • Willem de Ronde, Spaarne Gasthuis (NL)

Organisers:

  • Caroline Michaela Kistorp, Professor, Rigshospitalet & University of Copenhagen (DK)
  • Dorte Glintborg, Associate Professor, Odense University Hospital & University of Southern Denmark (DK)
  • Ebbe Eldrup, Associate Professor, Herlev University Hospital & University of Copenhagen (DK)
  • Jan Frystyk, Professor, Odense University Hospital & University of Southern Denmark (DK)

This meeting is intended for all clinicians and researchers interested in the topic of the meeting. Researchers from basic, translational and clinical science working in any field of endocrinology or metabolism research, and beyond, in academia, hospitals and industry, within Denmark and abroad, are welcome.

Seats will be filled on a first-come, first-served basis. 

Please note that you are not guaranteed a seat at the meeting if you do not meet the target group requirements. Priority is given to participants employed at Danish research and health institutions or in the life science industry, but a number of seats are reserved for participants employed at research and health institutions or in the life science industry abroad. If the event is overbooked, the DDEA reserves its right to select participants based on the defined requirements.

Dinner registration 

DDEA organises a networking dinner on 9 April. Participation in the dinner is free of charge. Please sign up for the dinner upon registration, and indicate whether you have any dietary requirements.

Accommodation

DDEA offers 1 night accomodation (check in 9 April, check out 10 April) for participants living outside of Fyn. You will be informed about your overnight accommodation by DDEA after the registration deadline

Latest cancellation date & no-show fee
Please note that it is free of charge to participate in the event, however the DDEA will charge a no-show fee of 1000 DKK if you do not show up and have not unregistered from the event by 31 March 2024, except in the case of illness or emergencies.

Tab Content

This is a basic text element.

Location

EVENT INFO

Copyright © 2023 Danish Diabetes and Endocrine Academy. All Rights Reserved • Privacy Policy